Skip to main content
PAS 2025 Meeting Main banner
Final Program


Schedule at a Glance
Icon Legend
Presentation Icons
Ticketed Event
Ticketed Event
Back
Evaluation ViewAttendees 43

Clinical Research

Hematology/Oncology

Neonatology

Well Newborn
Session Type: Clubs in Convention Center

Bilirubin Club: Alloimmunization and HDFN – New developments and ongoing global burden

Saturday, April 26, 2025
11:40am – 12:55pm HST
Location: Convention Center: 320
CE: 1.5

Disclosure(s):
Timothy M. Bahr, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Daniele De Luca, n/a: ASTRA ZENECA (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); CHIESI PHARMACEUTICALS (Ongoing) (Products/Services: Consultant, Speaker Honorarium including speakers bureau, symposia, and expert witness); GETINGE (Ongoing) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness); MEDTRONIC (Ongoing) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness); OAK HILL BIO (Ongoing) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); VYAIRE (Terminated, April 4, 2024) (Products/Services: Advisory Committee, Speaker Honorarium including speakers bureau, symposia, and expert witness)
Vinod K. Bhutani, MD, FAAP: I do not have any relevant financial / non-financial relationships with any proprietary interests.

The Bilirubin Club is a global academic forum to discuss and debate the biology and epidemiological burden of bilirubin in the context of research, clinical practice, public policy and therapeutics to promote human well-being. Alloimmunization and hemolytic disease of the fetus and newborn (HDFN) continue to result in many cases of severe anemia and hyperbilirubinemia in the United States and abroad. During the 2025 Bilirubin Club, topic experts will review the ongoing global burden of alloimmunization and HDFN. They will also discuss recent advances in therapies, patient perspectives, and efforts to standardize care for newborns affected with HDFN. Dr. Kenneth J. Moise, Jr is a world leader in research on alloimmunization and HDFN. He is recognized worldwide for his contributions in the fetal treatment of Rh disease, including the development of middle cerebral artery doppler for the non-invasive detection of fetal anemia and the use of free fetal DNA to determine the fetal RhD status. Ms. Bethany Weathersby is the founder and executive director at The Allo Hope Foundation. During her third pregnancy in 2013, Bethany was diagnosed with maternal alloimmunization (Kell antibodies).Unfortunately, her daughter, Lucy, was stillborn just shy of 20 weeks due to HDFN. Determined to continue growing her family, Bethany partnered with two maternal-fetal medicine specialists out of state who supported her throughout her next three pregnancies. In 2019, Bethany founded the Allo Hope Foundation to provide resources and support, and improve care practices for alloimmunized women and HDFN patients.

Learning Objectives:

  • Evaluate the burden of disease caused by alloimmunization and hemolytic disease of the fetus and newborn (HDFN) in the United States and globally
  • Appraise recent advances and ongoing research in prevention and treatment of HDFN
  • Support patient perspectives of families affected by HDFN and current advocacy efforts

Presentations:

  • 11:40am – 11:45am HST
    Neonatal Protocols for HDFN and Panel Discussion

    Speaker: Timothy M. Bahr, MD (he/him/his) – University of Utah

  • 11:45am – 11:55am HST
    Introduction and Welcome. Presentation of Pioneer Awards

    Speaker: Daniele De Luca, n/a (he/him/his) – APHP Paris Saclay University

  • 11:55am – 12:25pm HST
    Red Cell Alloimmunization 2025: Now and the Future

    Speaker: Kenneth J. Moise, Jr., MD (he/him/his) – Dell Medical School - UT Austin

  • 12:25pm – 12:55pm HST
    HDFN Disease Realities: A Patient-led Global Perspective

    Speaker: Bethany M. Weathersby, MEd (she/her/hers) – The Allo Hope Foundation